Experienced in Restrictive Cardiomyopathy (RCM)

Pedro V. Schwartzmann

Ribeirao Preto, SP, BR 
Experienced in Restrictive Cardiomyopathy (RCM)
Ribeirao Preto, SP, BR 
OverviewLocationsClinical Research

Overview

Pedro Schwartzmann practices in Ribeirao Preto, Brazil. Mr. Schwartzmann is rated as an Experienced expert by MediFind in the treatment of Restrictive Cardiomyopathy (RCM). His top areas of expertise are Heart Failure, Achalasia Microcephaly Syndrome, Microcephaly, Zika Virus Disease, and Heart Transplant.

His clinical research consists of co-authoring 34 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Restrictive Cardiomyopathy (RCM).

Gender
Male

Locations

Ribeirao Preto, SP, Brazil
Other Locations
Brazil
Goiania, GO 74075040, Brazil
Sao Paulo, SP, Brazil
Campinas, SP, Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT)
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT)
Enrollment Status: Completed
Publish Date: August 20, 2025
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3

34 Total Publications

Benefits of Patisiran on Functional Capacity in ATTR Cardiac Amyloidosis: Post Hoc Analysis of APOLLO-B.
Benefits of Patisiran on Functional Capacity in ATTR Cardiac Amyloidosis: Post Hoc Analysis of APOLLO-B.
Journal: JACC. Advances
Published: January 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Schwartzmann's expertise for a condition
ConditionClose
      View All 16 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile